相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Effects of different doses of esketamine intervention on postpartum depressive symptoms in cesarean section women: A randomized, double-blind, controlled clinical study
Si Qi Yang et al.
JOURNAL OF AFFECTIVE DISORDERS (2023)
Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression
Chenhui Ji et al.
BRAIN BEHAVIOR AND IMMUNITY (2022)
Use of ketamine and esketamine for depression: an overview of systematic reviews with meta-analyses
Tacio de Mendonca Lima et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2022)
GSK-3β inhibition protects human nucleus pulposus cell against oxidative stress-inducing apoptosis through mitochondrial pathway
Kai Zhu et al.
MOLECULAR BIOLOGY REPORTS (2022)
GSK-3β-mediated activation of NLRP3 inflammasome leads to pyroptosis and apoptosis of rat cardiomyocytes and fibroblasts
Shu-Hui Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Asperosaponin VI ameliorates the CMS-induced depressive-like behaviors by inducing a neuroprotective microglial phenotype in hippocampus via PPAR-γ pathway
Xue Jiang et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Dysregulation of adult hippocampal neuroplasticity in major depression: pathogenesis and therapeutic implications
Alexandria N. Tartt et al.
MOLECULAR PSYCHIATRY (2022)
Association Between Physical Activity and Risk of Depression A Systematic Review and Meta-analysis
Matthew Pearce et al.
JAMA PSYCHIATRY (2022)
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Haixia Wang et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Effect of Intraoperative Esketamine Infusion on Postoperative Sleep Disturbance After Gynecological Laparoscopy A Randomized Clinical Trial
Di Qiu et al.
JAMA NETWORK OPEN (2022)
Esketamine alleviates postoperative cognitive decline via stimulator of interferon genes/TANK-binding kinase 1 signaling pathway in aged rats
Yan Li et al.
BRAIN RESEARCH BULLETIN (2022)
Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
Dominika Psiuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Microglial NLRP3 inflammasome activates neurotoxic in-like mice
Shanshan Li et al.
CELL REPORTS (2022)
Albumin alleviated esketamine-induced neuronal apoptosis of rat retina through downregulation of Zn2+-dependent matrix metalloproteinase 9 during the early development
Kan Zhang et al.
BMC NEUROSCIENCE (2022)
Esketamine improves propofol-induced brain injury and cognitive impairment in rats
Guiping Xu et al.
TRANSLATIONAL NEUROSCIENCE (2022)
Inhibiting NLRP3 inflammasome attenuates apoptosis in contrast-induced acute kidney injury through the upregulation of HIF1A and BNIP3-mediated mitophagy
Qisheng Lin et al.
AUTOPHAGY (2021)
Saikosaponin A improved depression -like behavior and inhibited hippocampal neuronal apoptosis after cerebral ischemia through p-CREB/BDNF pathway
An-rong Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2021)
Neuroinflammation induces anxiety- and depressive-like behavior by modulating neuronal plasticity in the basolateral amygdala
Zhi-Heng Zheng et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
Isoliquiritin ameliorates depression by suppressing NLRP3-mediated pyroptosis via miRNA-27a/SYK/NF-κB axis
Yuanjie Li et al.
JOURNAL OF NEUROINFLAMMATION (2021)
Ibrutinib alleviates LPS-induced neuroinflammation and synaptic defects in a mouse model of depression
Weifen Li et al.
BRAIN BEHAVIOR AND IMMUNITY (2021)
TRPV4 inhibitor HC067047 produces antidepressant-like effect in LPS-induced depression mouse model
Wei Li et al.
NEUROPHARMACOLOGY (2021)
In the Clinic Depression
Robert M. McCarron et al.
ANNALS OF INTERNAL MEDICINE (2021)
NLRP3/caspase-1/GSDMD-mediated pyroptosis exerts a crucial role in astrocyte pathological injury in mouse model of depression
Shanshan Li et al.
JCI INSIGHT (2021)
Repeated, low-dose oral esketamine in patients with treatment-resistant depression: pilot study
Sanne Y. Smith-Apeldoorn et al.
BJPSYCH OPEN (2021)
PSD-93 up-regulates the synaptic activity of corticotropin-releasing hormone neurons in the paraventricular nucleus in depression
Xin-Ya Qin et al.
ACTA NEUROPATHOLOGICA (2021)
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders
Felicia Ceban et al.
CNS DRUGS (2021)
Hesperetin ameliorates diabetes-associated anxiety and depression-like behaviors in rats via activating Nrf2/ARE pathway
Xia Zhu et al.
METABOLIC BRAIN DISEASE (2021)
Early-life inflammation promotes depressive symptoms in adolescence via microglial engulfment of dendritic spines
Peng Cao et al.
NEURON (2021)
Ketamine: A tale of two enantiomers
Luke A. Jelen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2021)
Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer
Honglin Yan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
EPA is More Effective than DHA to Improve Depression-Like Behavior, Glia Cell Dysfunction and Hippcampal Apoptosis Signaling in a Chronic Stress-Induced Rat Model of Depression
Zhilan Peng et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Adiponectin peptide alleviates oxidative stress and NLRP3 inflammasome activation after cerebral ischemia-reperfusion injury by regulating AMPK/GSK-3β
Haixiao Liu et al.
EXPERIMENTAL NEUROLOGY (2020)
The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)
Min Zheng et al.
IMMUNOLOGICAL REVIEWS (2020)
A1 astrocytes contribute to murine depression-like behavior and cognitive dysfunction, which can be alleviated by IL-10 or fluorocitrate treatment
He-Yang Zhang et al.
JOURNAL OF NEUROINFLAMMATION (2020)
The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Eleonore Beurel et al.
NEURON (2020)
Suppressing the Na+/H+ exchanger 1: a new sight to treat depression
Xueyang Deng et al.
CELL DEATH & DISEASE (2019)
Esketamine for treatment resistant depression
Jennifer Swainson et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome
Lingbin Sun et al.
CELL DEATH & DISEASE (2019)
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2019)
Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway
Burak Arioz et al.
FRONTIERS IN IMMUNOLOGY (2019)
The role of GSK-3 in treatment-resistant depression and links with the pharmacological effects of lithium and ketamine: A review of the literature
J. F. Costemale-Lacoste et al.
ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE (2016)
Erythropoietin prevents PC12 cells from 1-methyl-4-phenylpyridinium ion-induced apoptosis via the Akt/GSK-3β/caspase-3 mediated signaling pathway
Yan Wu et al.
APOPTOSIS (2007)